Physician
Doman, Tara
Doman, Tara was paid $1.17M by Medicaid between Jan 2018 and Dec 2024, across 47 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 35% of everything it billed.
33Billing provider infoDOMAN, TARA
NAPERVILLE, IL 60563
NAPERVILLE, IL 60563
33aNPI1407050826assigned 06/11/2007
33bProvider typePediatrics Physician
28Total paid$1.17M
24GClaims25,949
24DCodes billed47
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Illinois
Rank by total paid#119 of 1,805
Median peer was paid$55K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,032 | $127K | |
| 2019 | 1,870 | $93K | |
| 2020 | 2,412 | $95K | |
| 2021 | 3,123 | $134K | |
| 2022 | 5,304 | $240K | |
| 2023 | 5,142 | $218K | |
| 2024incomplete | 5,066 | $258K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 35% | 5,286 | 4,335 | $408K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 4,383 | 3,716 | $216K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 9.9% | 809 | 650 | $115K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.1% | 1,071 | 843 | $82K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.5% | 927 | 693 | $64K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.7% | 719 | 636 | $55K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.6% | 515 | 429 | $42K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.6% | 817 | 742 | $19K |
| 96127 | 1.5% | 954 | 811 | $17K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.4% | 49 | 37 | $17K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.1% | 830 | 691 | $13K |
| 96160 | 1.0% | 801 | 609 | $12K |
35 more codes
| 92551 | <1% | 753 | $11K | |
| 90686 | <1% | 957 | $10K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 273 | $10K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 201 | $8K |
| 90698 | <1% | 437 | $6K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 389 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 262 | $5K |
| 90671 | <1% | 231 | $5K | |
| 85018 | <1% | 1,822 | $4K | |
| 83655 | <1% | 288 | $3K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 81 | $3K |
| D1206 | Topical application of fluoride varnish | <1% | 127 | $3K |
| 90674 | <1% | 195 | $3K | |
| 90670 | <1% | 240 | $3K | |
| 90680 | <1% | 184 | $3K | |
| 83718 | <1% | 291 | $2K | |
| 99173 | <1% | 288 | $2K | |
| 36416 | <1% | 477 | $2K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 88 | $2K |
| 99174 | <1% | 184 | $1K | |
| 90661 | <1% | 77 | $1K | |
| 82465 | <1% | 284 | $1K | |
| 90633 | <1% | 81 | $1K | |
| 90651 | <1% | 100 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 17 | $872.27 |
| 90700 | <1% | 68 | $809.36 | |
| 94760 | <1% | 197 | $732.88 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 52 | $616.88 |
| 90619 | <1% | 40 | $614.45 | |
| 90715 | <1% | 29 | $434.79 | |
| 90744 | <1% | 22 | $367.62 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 12 | $307.80 |
| 90656 | <1% | 13 | $217.23 | |
| 81002 | <1% | 16 | $41.60 | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.